A pilot study on the use of outpatient fractionated ifosfamide, carboplatin and etoposide (ICE) and pegfilgrastim as a salvage and mobilizing regimen for relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma

Bone Marrow Transplant. 2012 Jul;47(7):1001-2. doi: 10.1038/bmt.2011.197. Epub 2011 Oct 17.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Ambulatory Care / methods
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Hodgkin Disease / drug therapy*
  • Humans
  • Ifosfamide / administration & dosage
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male
  • Middle Aged
  • Pilot Projects
  • Polyethylene Glycols
  • Recombinant Proteins / administration & dosage
  • Salvage Therapy / methods*
  • Young Adult

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • pegfilgrastim
  • Polyethylene Glycols
  • Etoposide
  • Carboplatin
  • Filgrastim
  • Ifosfamide